The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin (Q38620403)

4 September 2017

1 reference

title

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin (English)

1 reference

4 September 2017

1 reference

1 reference

Eschbach JW

1

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

4 September 2017

1 reference

4 September 2017

volume

35

1 reference

4 September 2017

issue

1

1 reference

4 September 2017

page(s)

134-148

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1989.18

4 September 2017

exact match

0 references

cites work

Role of the kidney in erythropoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Blood and bone marrow studies in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Plasma erythropoietin in chronic uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

ERYTHROPOIESIS IN ANEPHRIC MAN.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Erythropoiesis in patients with renal failure undergoing chronic dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Inhibition of Cell Proliferation in Renal Failure and its Significance to the Uraemic Syndrome: A Review

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Mechanism of the anemia of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The anaemia of chronic renal insufficiency; the effect of serum from azotaemic patients on the maturation of normoblasts in suspension cultures

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Inhibitor of marrow thymidine incorporation from sera of patients with uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Disorders of Red Blood Cell Production in Uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Improvement in the Anemia of Chronic Renal Failure with Fluoxymesterone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Erythropoiesis and Erythropoietin in Patients with Chronic Renal Failure Treated with Hemodialysis and Testosterone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

A comparison of androgens for anemia in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Clinical effects of bilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Cloning and expression of the human erythropoietin gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Isolation and characterization of genomic and cDNA clones of human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Absence of Anemia in Maintenance Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Physical activity and employment status of patients on maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Anemia of end-stage renal disease (ESRD).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Reticulocytosis in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The burr red cell and azotaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Recombinant human erythropoietin: implications for nephrology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The kidney and erythropoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The bleeding disorder of uraemia. A qualitative platelet defect

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Effect of parathyroid hormone on erythropoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Ribonuclease inhibition of erythropoiesis in anemia of uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Anaemia of chronic renal failure. Polyamines are not raised in uraemic serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The anemia of end-stage renal disease: hematopoietic progenitor cell response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

The anaemia of chronic renal failure in sheep: studies in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Is anaemia during continuous ambulatory peritoneal dialysis really better than during haemodialysis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Anemia of the Regular Hemodialysis Patient and its Treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Characterization of the anemia associated with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Uremic toxins and platelet function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1989.18

1 reference

7 January 2021

The bleeding time as a screening test for evaluation of platelet function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Treatment of the bleeding tendency in uremia with cryoprecipitate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

A controlled trial of nandrolone decanoate in the treatment of uremic anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Ferritin in serum. Clinical and biochemical implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Iron overload and mobilization in long-term hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Clinical consequences of acquired transfusional iron overload in adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Iron Absorption in Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Hypersplenism in the uremic hemodialyzed patient. The effect of splenectomy--effect on transplantation and proposed mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Splenectomy for anaemia in patients on regular haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Characterization and biological effects of recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Erythropoietin: gene cloning, protein structure, and biological properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Iron balance in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Iron kinetics in healthy individuals and in chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Myelofibrosis and renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Silicone-induced splenomegaly: treatment of pancytopenia by splenectomy in a patient on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Oxidative Injury to Erythrocytes, Cell Rigidity, and Splenic Hemolysis in Hemodialyzed Uremic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Treatment of a seven-year-old child with end-stage renal disease and hemosiderosis by recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.18

7 January 2021

Identifiers

DOI

10.1038/KI.1989.18

1 reference

Dimensions Publication ID

4 September 2017

1019029161

0 references

1 reference